Latest News

Is a cell-depleting DMT safe prior to HSCT?


Long-acting disease-modifying therapies do not appear to increase the risk of complications following autologous hematopoietic stem cell transplantation (aHSCT), according to a retrospective study from Sweden (Kvistad et al. J Neurol Neurosurg Psychiatry 2022;93:844-848). Read More


COVID update: the 7th wave


Ontario and Quebec have announced that they are now seeing a seventh wave of COVID-19 infections, although case numbers are uncertain due to a lack of reporting. Health Canada reports 21,317 new cases for the week ending July 8, but acknowledges that this is an underestimate ( The Northwest Territories and Nunavut no longer publish COVID case numbers while Saskatchewan posts case numbers only once a month. Read More